[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344509-105":59,"doc-detail-344509-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","investigating-harms-of-testing-for-ovarian-cancer-psychological-outcomes-and-cancer-conversion-rates-a-cohort-study-embedded-in-the-multicentre-rockets-prospective-diagnostic-study","Investigating harms of testing for ovarian cancer - psychological outcomes and cancer conversion rates - A cohort study embedded in the multicentre ROCkeTS prospective diagnostic study","","Objective: Investigate psychological correlates in women with suspected ovarian cancer referred via the fast-track pathway, examine how anxiety and distress change at 12 months after testing, and quantify cancer conversion rates by age and referral pathway. Design: Single-arm prospective cohort study. Setting: Multicentre secondary care, including outpatient clinics and emergency admissions. Population: 2596 symptomatic women with raised CA125 and/or abnormal imaging. Methods: STAI-6 and IES-R questionnaires at recruitment and 12 months. Main outcomes: Anxiety and distress, and ovarian cancer conversion rates by age, menopausal status, and referral pathway. Results: High levels of moderate-to-severe distress and anxiety at recruitment; most participants remained unchanged/worsened at 12 months. Conclusions: Diagnostic testing is associated with severe anxiety and distress, with younger women most vulnerable; evidence supports reducing testing for under-40 groups to reduce harms.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/investigating-harms-of-testing-for-ovarian-cancer-psychological-outcomes-and-cancer-conversion-rates-a-cohort-study-embedded-in-the-multicentre-rockets-prospective-diagnostic-study/344509/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/investigating-harms-of-testing-for-ovarian-cancer-psychological-outcomes-and-cancer-conversion-rates-a-cohort-study-embedded-in-the-multicentre-rockets-prospective-diagnostic-study/344509.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of this cohort study?","Question",{"text":112,"@type":113},"To assess psychological correlates in women with suspected ovarian cancer referred through a fast-track pathway, track anxiety and distress at 12 months post-testing, and report cancer conversion rates by age and referral pathway.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were anxiety and distress measured and when?",{"text":117,"@type":113},"Anxiety and distress questionnaires were completed at recruitment and at 12 months using STAI-6 and the Impact of Event Scale – Revised (IES-r), for eligible participants who had not undergone surgery or biopsy within 3 months.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key findings about psychological outcomes at recruitment and 12 months?",{"text":121,"@type":113},"At recruitment, 52.1% experienced moderate-to-severe distress and 68.6% experienced anxiety. At 12 months, the anxiety and distress clinical category remained unchanged or worsened for 76% of respondents.",{"name":123,"@type":110,"acceptedAnswer":124},"What did the study conclude regarding testing harms and recommendations for younger women?",{"text":125,"@type":113},"Women undergoing diagnostic testing showed severe anxiety and distress, with younger women particularly vulnerable. The study argues for targeting support and reducing testing in women under 40 to reduce harms.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},344509,1790319097,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":14,"preview_urls":150},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Accepted: 4 March 2024  \nDOI: 10. 1111/1471-0528 .17813  \nR E S E A R C H A R T I C L E  \nInvestigating harms of testing for ovarian cancer – psychological outcomes and cancer conversion rates in women with symptoms of ovarian cancer: A cohort study embedded in the multicentre ROCkeTS prospective diagnostic study  \nFong Lien Kwong1,2  | Caroline Kristunas3 | Clare Davenport1 | Ridhi Aggarwal1 | Jon Deeks1 | Sue Mallett4 | Sean Kehoe5 | Dirk Timmerman6,7 | Tom Bourne8 | Hilary Stobart9 | Richard Neal10 | Usha Menon11 | Alex Gentry-Maharaj11 | Lauren Sturdy1 | Ryan Ottridge1 | Sudha Sundar2,3  | on behalf of the ROCkeTS collaborators  \n1Institute of Applied Health Research, University of Birmingham, Birmingham, UK 2Pan Birmingham Gynaecological Cancer Centre, City Hospital, Birmingham, UK 3Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK 4Centre for Medical Imaging, University College London, London, UK  \n5St Peter's College, University of Oxford, Oxford, UK  \n6Department of Development and Regeneration, KU Leuven, Leuven, Belgium 7Department of Obstetrics and Gynaecology, University Hospitals KU Leuven, Leuven, Belgium  \n8Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK  \n9Patient Representative, Birmingham, UK 10University of Exeter Medical School, University of Exeter, Exeter, UK  \n11Institute of Clinical Trials and Methodology, University College London, London, UK  \nCorrespondence  \nSudha Sundar, Pan Birmingham Gynaecological Cancer Centre, Dudley Rd, Birmingham, B18 7QH, UK.  \nEmail: [s.s.sundar@bham.ac.uk](s.s.sundar@bham.ac.uk)  \nFunding information  \nHealth Technology Assessment Programme; National Institute for Health and Care Research  \nAbstract  \nObjective: To investigate psychological correlates in women referred with suspected ovarian cancer via the fast-track pathway, explore how anxiety and distress levels change at 12 months post-testing, and report cancer conversion rates by age and referral pathway.  \nDesign: Single-arm prospective cohort study.  \nSetting: Multicentre. Secondary care including outpatient clinics and emergency admissions.  \nPopulation: A cohort of 2596 newly presenting symptomatic women with a raised CA125 level, abnormal imaging or both.  \nMethods: Women completed anxiety and distress questionnaires at recruitment and at 12 months for those who had not undergone surgery or a biopsy within 3 months of recruitment.  \nMain outcome measures: Anxiety and distress levels measured using a six-item short form of the State–Trait Anxiety Inventory (STAI-6) and the Impact of Event Scale – Revised (IES-r) questionnaire. Ovarian cancer (OC) conversion rates by age, menopausal status and referral pathway.  \nResults: Overall, 1355/2596 (52.1%) and 1781/2596 (68.6%) experienced moderateto-severe distress and anxiety, respectively, at recruitment. Younger age and emergency presentations had higher distress levels. The clinical category for anxiety and distress remained unchanged/worsened in 76% of respondents at 12 months, despite a non-cancer diagnosis. The OC rates by age were 1.6%(95% CI 0.5%–5.9%) forage \u003C40 years and 10.9%(95% CI 8.7%–13.6%) for age ≥40 years. In women referred through fast-track pathways, 3.3%(95% CI 1.9%–5.7%) of pre- and 18.5%(95% CI 16.1%–21.0%) of postmenopausal women were diagnosed with OC.  \nConclusions: Women undergoing diagnostic testing display severe anxiety and distress. Younger women are especially vulnerable and should be targeted for support. Women under the age of 40 years have low conversion rates and we advocate reducing testing in this group to reduce the harms of testing.  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2024 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wil","cbCaifSoZaZxGWSJ","https://ap.wps.com/l/cbCaifSoZaZxGWSJ","pdf",493898,11,"English","# Introduction\n# Objective\n# Design\n# Setting\n# Population\n# Methods\n# Main outcome measures\n# Results\n# Conclusions","[{\"question\":\"What is the main objective of this cohort study?\",\"answer\":\"To assess psychological correlates in women with suspected ovarian cancer referred through a fast-track pathway, track anxiety and distress at 12 months post-testing, and report cancer conversion rates by age and referral pathway.\"},{\"question\":\"How were anxiety and distress measured and when?\",\"answer\":\"Anxiety and distress questionnaires were completed at recruitment and at 12 months using STAI-6 and the Impact of Event Scale – Revised (IES-r), for eligible participants who had not undergone surgery or biopsy within 3 months.\"},{\"question\":\"What were the key findings about psychological outcomes at recruitment and 12 months?\",\"answer\":\"At recruitment, 52.1% experienced moderate-to-severe distress and 68.6% experienced anxiety. At 12 months, the anxiety and distress clinical category remained unchanged or worsened for 76% of respondents.\"},{\"question\":\"What did the study conclude regarding testing harms and recommendations for younger women?\",\"answer\":\"Women undergoing diagnostic testing showed severe anxiety and distress, with younger women particularly vulnerable. The study argues for targeting support and reducing testing in women under 40 to reduce harms.\"}]","Investigating harms of testing for ovarian cancer - psychological outcomes and cancer conversion rates - A cohort study embedded in the multicentre ROCkeTS prospective diagnostic study | PDF",1790054173,28,[151,155],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/9c1df3335796f30ed1b5d60727d9b574.webp",983,1291,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/bb2870f72d6ecd30f4fa24272169a173.webp",982,1290]